congo red has been researched along with Huntington Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahlke, C; Sánchez, I; Yuan, J | 1 |
| Morton, AJ; Pallier, PN; Wanderer, J; Wood, NI | 1 |
| Bacos, K; Björkqvist, M; Brundin, P; Luts, L; Maat-Schieman, ML; Mulder, H; Petersén, A; Roos, RA; Sundler, F; Wierup, N | 1 |
| Boeddrich, A; Heiser, V; Lehrach, H; Lurz, R; Nordhoff, E; Scherzinger, E; Schugardt, N; Wanker, EE | 1 |
| Bates, GP; Cooper, GJ; Faull, RL; Holloway, H; Mangiarini, L; McGowan, DP; Snell, RG; van Roon-Mom, W | 1 |
| Bates, GP; Hockly, E; Klunk, WE; Li, XJ; Mahal, A; Murray, KD; Portier, R; Smith, DL; Wanker, E; Woodman, B | 1 |
6 other study(ies) available for congo red and Huntington Disease
| Article | Year |
|---|---|
Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders.
Topics: Adenosine Triphosphate; Animals; Caspases; Cell Death; Congo Red; Disease Models, Animal; Enzyme Activation; HeLa Cells; Humans; Huntington Disease; Mice; Mice, Transgenic; Neurodegenerative Diseases; Peptides; Protein Binding; Protein Structure, Quaternary; Recombinant Fusion Proteins; Survival Rate; Trinucleotide Repeat Expansion; Weight Loss | 2003 |
Systemic administration of Congo red does not improve motor or cognitive function in R6/2 mice.
Topics: Animals; Blood-Brain Barrier; Body Weight; Brain; Cognition; Cognition Disorders; Congo Red; Dyskinesias; Female; Humans; Huntington Disease; Inclusion Bodies; Locomotion; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Neurons; Neuroprotective Agents; Recovery of Function; Treatment Failure | 2007 |
Islet beta-cell area and hormone expression are unaltered in Huntington's disease.
Topics: Adult; Aged; Aged, 80 and over; Congo Red; Female; Gene Expression; Humans; Huntington Disease; Immunochemistry; In Situ Hybridization; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Male; Middle Aged; Peptide Hormones; Transcription, Genetic | 2008 |
Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy.
Topics: Animals; Antibodies, Monoclonal; Benzoates; Benzothiazoles; Biphenyl Compounds; Congo Red; COS Cells; Gossypol; Humans; Huntingtin Protein; Huntington Disease; Melatonin; Nerve Tissue Proteins; Nuclear Proteins; Peptides; Rifampin; Thiazoles | 2000 |
Amyloid-like inclusions in Huntington's disease.
Topics: Alzheimer Disease; Amyloid; Animals; Birefringence; Brain; Congo Red; Humans; Huntington Disease; Mice; Microscopy, Confocal; Microscopy, Polarization; Neurons; Staining and Labeling | 2000 |
Inhibition of polyglutamine aggregation in R6/2 HD brain slices-complex dose-response profiles.
Topics: Animals; Benzoates; Biphenyl Compounds; Cells, Cultured; Coloring Agents; Congo Red; Creatine; Cysteine Endopeptidases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Energy Metabolism; Female; Hippocampus; Huntingtin Protein; Huntington Disease; Immunohistochemistry; Male; Mice; Mice, Transgenic; Multienzyme Complexes; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Nuclear Proteins; Organ Culture Techniques; Peptides; Proteasome Endopeptidase Complex; Protein Folding; Trinucleotide Repeat Expansion; Ubiquitin | 2001 |